ESCRS - Improving intermediate vision

Improving intermediate vision

New Mono-EDOF lens provides intermediate vision without sacrifice of distance vision

Improving intermediate vision
Roibeard O’hEineachain
Roibeard O’hEineachain
Published: Saturday, June 6, 2020
Ewa Mrukwa-Kominek MD, PhD
The new Tecnis® Eyhance (Johnson & Johnson) refractive aspheric monofocal extended depth of focus (EDOF) IOL appears to provide very good distance vision and slightly improved intermediate distances vision compared to a standard aspheric monofocal IOL, reports Ewa Mrukwa-Kominek MD, PhD, University Clinical Centre Katowice, Poland. In a pilotage study involving 10 patients who underwent implantation of the new Eyhance IOL, uncorrected distance visual acuity (UCDVA) and uncorrected intermediate visual acuity (UCIVA) was significantly better postoperatively (p<0.05) than it was preoperatively. Patients also reported significant improvement in the performance of daily activities connected to vision, she told the 24th Winter Meeting of the ESCRS in Marrakech, Morocco. Prof Mrukwa-Kominek and her associates performed the cataract procedures with standard ultrasound phacoemulsification. They measured the preoperative and postoperative refractive error using the maximum plus technique. They calculated the power of implanted lenses for emmetropia using the Barret TK Universal II formula. These ranged from 19.0D to 25.5D (mean 21.3D). One month after the procedure, both the mean uncorrected distance visual acuity (UCDVA) and the mean uncorrected intermediate visual acuity (UCIVA) were significantly better than they were preoperatively (p<0.05). Postoperatively the mean UCDVA was Snellen 0.9, compared to 0.2 preoperatively, and the mean UCIVA, using the Jaeger standard at 66cm J10 preoperatively and J6 postoperatively. In addition, the average refractive error improved from -1.50D to -0.25D. No adverse effects or decentration of the IOL were observed, Prof Mrukwa-Kominek said. The patients’ responses to the Catquest-9SF questionnaire showed significant improvement of performance of daily activities after implantation of the Tecnis Eyhance lens. Prior to the procedure, seven patients said they were very dissatisfied or fairly dissatisfied with their vision. One month postoperatively, nine patients said they were very satisfied or fairly satisfied with their vision, Prof Mrukwa-Kominek said. The new Tecnis one-piece IOL (ZCB00) has the same base geometry as all other Tecnis one-piece lenses but has a continuous aspheric surface. The dioptric power of the lens changes from the periphery to the centre, without diffractive rings or refractive zones, in a manner designed to provide better intermediate distance vision compared to a monofocal aspherical lens. In addition, the lens material provides simultaneous correction of chromatic aberration. “It seems that the innovative Tecnis Eyhance intraocular monofocal lenses with ‘extended depth of focus’ provide very good distant vision and slightly improved vision at intermediate distances. Implantation of Tecnis Eyhance IOLS can be considered in all patients who have opted for a monofocal lens implant,” Prof Mrukwa-Kominek concluded.
Tags: intermediate vision
Latest Articles
Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...